Request for Proposals - Independent Medical Education

The grant review process evaluates all grant applications based upon perceived educational need, design, scientific rigor of the proposal and compliance with both industry and argenx independent medical education guidelines.

The approval of a proposal will depend on available funding and alignment with the educational areas of interest as outlined in the argenx IME RFP. All decisions regarding grant proposals are made through a formal, grant review and decision-making process by the argenx independent medical education review committee.

All submitted grant proposals are reviewed regardless of whether they were submitted in response to a current RFP, however, RFP responsive proposals will be prioritized. Should your organization be interested in submitting a proposal, please click on the hyperlink below for the Grants portal to start the process of submission. For any questions, please reach out to

Current Open Request for Proposals:


Clinical Management of Glucocorticoid Toxicity in Treatment of gMG

argenx supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, and education) to improve patient outcomes in areas of unmet medical need that are aligned with argenx medical and scientific strategies. Through this RFP, it is our intent to support IME programs in the following areas of interest.

Areas of Interest

  • Tools and resources currently available to improve systematic surveillance for glucocorticoid adverse events in the gMG clinical setting (e.g. Metabolic Glucocorticoid Toxicity Index) 
  • Considerations for more effective clinical management of patients given common comorbidities of MG and how known steroid toxicities may contribute to their worsening. 
  • Role of new and emerging non-steroid gMG therapies (e.g. FcRn inhibitors) in the current treatment paradigm to assist clinicians in managing the adverse events of glucocorticoid therapy while improving outcomes for gMG patients. 
  • Quality of life data, health economic data with new gMG treatment, real world data on the impact of FcRn inhibitors in supporting steroid sparing treatment goals.  
  • Considerations for future MG treatment guidelines to include glucocorticoid adverse events surveillance and management.  

Target Audience

  • Minimum CME/CE requirement, 1 credit for all proposals 
  • Educational credits in North America and Europe  
  • MDs, NPs, PAs, PharmD/RPh in neurology, neuromuscular, or neuroimmunology disease space. 

RFP Timeline

  • We will be accepting proposals until December 15th.  

Questions regarding this RFP must be submitted to To access the portal to submit a grant application please register and log into the argenx Grants portal. Thank you for your interest in argenx.

argenx grants
Together We Discover